02.27.26 -- The Quiet Case For Trusting CDMO Pricing

Experts discuss best practices and tips across a range of topics, including program management, automation, and secondary services.

Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.

Expedited development programs require adapting to accelerated development timelines. The challenge is to build a strategy that maintains the integrity, quality, and timeliness of the manufacturing process.

Drawing on experience from hundreds of successful transfers, our experts recognize that informed decision-making at critical junctures can determine whether a program maintains momentum or loses it.

Choosing the right CDMO is essential for biotech commercialization. Key factors include regulatory expertise, integrated services, communication, flexibility, and strong technical and packaging capabilities

3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.

Companies seeking access to the Brazilian market must navigate more rigorous regulatory requirements, increased scrutiny, and heightened enforcement of good manufacturing practices.

To reduce CO₂ emissions and recycle higher volumes of solvent, drug manufacturers must engineer specialized approaches with technologies that can be adapted to accommodate different products.